At the time of writing, Structure Therapeutics Inc ADR [GPCR] stock is trading at $21.76, up 17.43%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GPCR shares have gain 44.58% over the last week, with a monthly amount drifted -3.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on January 08, 2025, and set its price target to $50. On December 04, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $80 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $118 on September 23, 2024. JP Morgan initiated its recommendation with a Overweight and recommended $65 as its price target on May 21, 2024. Cantor Fitzgerald started tracking with a Overweight rating for this stock on April 09, 2024, and assigned it a price target of $65. In a note dated October 19, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $90 on this stock.
For the past year, the stock price of Structure Therapeutics Inc ADR fluctuated between $13.22 and $62.74. Currently, Wall Street analysts expect the stock to reach $92.4 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $21.76 at the most recent close of the market. An investor can expect a potential return of 324.63% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.16 and Total Capital is -0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.61 points at the first support level, and at 17.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.04, and for the 2nd resistance point, it is at 26.32.
Ratios To Look Out For
It is important to note that Structure Therapeutics Inc ADR [NASDAQ:GPCR] has a current ratio of 24.74. As well, the Quick Ratio is 24.74, while the Cash Ratio is 4.71.
